In addition to the GABA-A receptor, studies have demonstrated that phosphorylation at sites Y230 and Y404, subunits of the GABA-B receptor GABAB1e, interact with PTPN12, which affects the EGFR/AKT signaling pathway and promotes the malignancy of breast cancer cells. The gene discussed is AKT1; the disease is breast carcinoma.